Almanack Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $576K | Sell |
739
-280
| -27% | -$218K | 0.09% | 111 |
|
|
2025
Q1 | $842K | Buy |
1,019
+355
| +53% | +$293K | 0.17% | 68 |
|
|
2024
Q4 | $513K | Sell |
664
-308
| -32% | -$238K | 0.08% | 109 |
|
|
2024
Q3 | $861K | Buy |
972
+6
| +0.6% | +$5.32K | 0.14% | 84 |
|
|
2024
Q2 | $875K | Buy |
+966
| New | +$875K | 0.15% | 81 |
|
|
2024
Q1 | – | Sell |
-891
| Closed | -$752K | – | 180 |
|
|
2023
Q4 | $752K | Sell |
891
-1,544
| -63% | -$1.3M | 0.14% | 75 |
|
|
2023
Q3 | $1.31M | Buy |
2,435
+1,031
| +73% | +$554K | 0.25% | 47 |
|
|
2023
Q2 | $659K | Buy |
1,404
+302
| +27% | +$142K | 0.12% | 77 |
|
|
2023
Q1 | $378K | Sell |
1,102
-415
| -27% | -$143K | 0.07% | 108 |
|
|
2022
Q4 | $555K | Sell |
1,517
-1,092
| -42% | -$399K | 0.12% | 77 |
|
|
2022
Q3 | $844K | Buy |
2,609
+991
| +61% | +$321K | 0.17% | 59 |
|
|
2022
Q2 | $525K | Buy |
1,618
+376
| +30% | +$122K | 0.05% | 224 |
|
|
2022
Q1 | $356K | Buy |
1,242
+315
| +34% | +$90.3K | 0.03% | 319 |
|
|
2021
Q4 | $256K | Buy |
+927
| New | +$256K | 0.02% | 410 |
|
|
2020
Q4 | – | Sell |
-3,602
| Closed | -$528K | – | 434 |
|
|
2020
Q3 | $528K | Buy |
3,602
+190
| +6% | +$27.9K | 0.07% | 198 |
|
|
2020
Q2 | $560K | Buy |
+3,412
| New | +$560K | 0.1% | 115 |
|